These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 34363223)
1. ICOS Yao L; Guo J; Gui J; Bai F; Xin R; Deng Y; Wang S; Li H Clin Exp Pharmacol Physiol; 2021 Nov; 48(11):1566-1575. PubMed ID: 34363223 [TBL] [Abstract][Full Text] [Related]
2. The Imbalance of Circulating Follicular Helper T Cells and Follicular Regulatory T Cells Is Associated With Disease Activity in Patients With Ulcerative Colitis. Long Y; Xia C; Xu L; Liu C; Fan C; Bao H; Zhao X; Liu C Front Immunol; 2020; 11():104. PubMed ID: 32117258 [TBL] [Abstract][Full Text] [Related]
3. Circulating follicular regulatory T cells could inhibit Ig production in a CTLA-4-dependent manner but are dysregulated in ulcerative colitis. Wang S; Fan T; Yao L; Ma R; Yang S; Yuan F Mol Immunol; 2019 Oct; 114():323-329. PubMed ID: 31442916 [TBL] [Abstract][Full Text] [Related]
4. The shifted balance between circulating follicular regulatory T cells and follicular helper T cells in patients with ulcerative colitis. Wang X; Zhu Y; Zhang M; Hou J; Wang H; Jiang Y; Wang H; Gao P Clin Sci (Lond); 2017 Dec; 131(24):2933-2945. PubMed ID: 29109300 [TBL] [Abstract][Full Text] [Related]
5. Circulating Treg cells from patients with cerebral aneurysms displayed deficiency in ICOS expression and function. Zhao MG; Peng C; Li LM; Chen L; Zhang HF Clin Exp Pharmacol Physiol; 2020 Dec; 47(12):1923-1931. PubMed ID: 32726458 [TBL] [Abstract][Full Text] [Related]
6. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells. Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797 [TBL] [Abstract][Full Text] [Related]
7. Activated inducible co-stimulator-positive programmed cell death 1-positive follicular helper T cells indicate disease activity and severity in ulcerative colitis patients. Long Y; Zhao X; Liu C; Xia C; Liu C Clin Exp Immunol; 2020 Oct; 202(1):106-118. PubMed ID: 32621310 [TBL] [Abstract][Full Text] [Related]
8. The prevalence and function of CD4 Cha Z; Gu H; Zang Y; Wang Z; Li J; Huang W; Qin A; Zhu L; Tu X; Cheng N; Song H; Qian B Int Immunopharmacol; 2018 Aug; 61():132-139. PubMed ID: 29870918 [TBL] [Abstract][Full Text] [Related]
9. ICOS Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099 [TBL] [Abstract][Full Text] [Related]
10. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665 [TBL] [Abstract][Full Text] [Related]
11. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells. Wu HY; Quintana FJ; Weiner HL J Immunol; 2008 Nov; 181(9):6038-50. PubMed ID: 18941193 [TBL] [Abstract][Full Text] [Related]
12. T follicular helper cell-mediated IL-21 production suppresses FOXP3 expression of T follicular regulatory-like cells in diffuse large B cell lymphoma patients. Ma X; Zha J; He J; Chen L; Huang J; Wu W; Tian P; Qian BH; Yu L; Jiang Y; Xu B Hum Immunol; 2020 Aug; 81(8):452-459. PubMed ID: 32534760 [TBL] [Abstract][Full Text] [Related]
13. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients. Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292 [TBL] [Abstract][Full Text] [Related]
14. ICOS costimulation is indispensable for the differentiation of T follicular regulatory cells. Panneton V; Mindt BC; Bouklouch Y; Bouchard A; Mohammaei S; Chang J; Diamantopoulos N; Witalis M; Li J; Stancescu A; Bradley JE; Randall TD; Fritz JH; Suh WK Life Sci Alliance; 2023 Apr; 6(4):. PubMed ID: 36754569 [TBL] [Abstract][Full Text] [Related]
15. Increased CD4 Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423 [TBL] [Abstract][Full Text] [Related]
16. Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity. D'Ambrosio A; Cossu A; Amendola A; Zandri A; Butera A; Sanchez M; Biffoni M; Pronio A; Montesani C; Kohn A; Pica R; Boirivant M J Crohns Colitis; 2016 Mar; 10(3):346-53. PubMed ID: 26589955 [TBL] [Abstract][Full Text] [Related]
17. Sirolimus therapy restores the PD-1+ICOS+Tfh:CD45RA-Foxp3 Wang Y; Guo H; Liang Z; Feng M; Wu Y; Qin Y; Zhao X; Gao C; Liu G; Luo J Mol Immunol; 2022 Jul; 147():90-100. PubMed ID: 35523039 [TBL] [Abstract][Full Text] [Related]
18. Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action. Sitohy B; Hammarström S; Danielsson A; Hammarström ML Clin Exp Immunol; 2008 Feb; 151(2):326-33. PubMed ID: 18190460 [TBL] [Abstract][Full Text] [Related]
19. ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection. Redpath SA; van der Werf N; Cervera AM; MacDonald AS; Gray D; Maizels RM; Taylor MD Eur J Immunol; 2013 Mar; 43(3):705-15. PubMed ID: 23319295 [TBL] [Abstract][Full Text] [Related]